NeuroMetrix Reports Results of Large Clinical Study of Quell Wearable Pain Relief Medical Device Investing
Zynerba Pharmaceuticals Initiates Open-Label Phase 2 Trial of ZYN002 in Developmental and Epileptic Encephalopathies Pharmaceutical Investing
Wave Life Sciences and Deep Genomics Form Collaboration to Discover Novel Therapies for Genetic Neuromuscular Disorders Biotech Investing
Neuralstem Announces First Surgery Completed in Cervical Cohort of Phase 1 Clinical Trial in Patients with Chronic Spinal Cord Injury Biotech Investing
BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Previously Treated Hepatocellular Carcinoma Biotech Investing
Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics Genetics Investing
VistaGen Therapeutics Receives European Patent regarding Methods of Production for AV-101 Pharmaceutical Investing
